Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.  The Fool has written over 900 articles on Bristol-Myers Squibb.
2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...



Stock Performance

View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $56.44
Prev Close: $55.77
Open: $55.92
Bid: $56.14
Ask: $56.39
Day's Range: $55.88 - $56.47
52wk Range: $46.01 - $77.12
Volume: 11,381,429
Avg Vol 16,968,659
Market Cap: $94B
P/E (ttm): 21.05
EPS (ttm): $2.65
Div & Yield: $1.56 (2.8%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1757 Outperform
114 Underperform
CAPS All Stars
 
431 Outperform
18 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

81% Approve

Based on 195 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers